3 Pot Stocks That Can Soar After Q3 Earnings

Pot stocks such as Turlieve Cannabis (CNSX:TRUL) have the potential to end 2020 on a high if they beat market estimates in Q3.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The earnings season has started, and several companies will be announcing their results in the next few days. Analysts and investors keep a close eye on the company’s performance as well as management guidance, which generally drives the stock prices in the near term.

Pot stocks have had a volatile year, but a few have managed to gain momentum on the back of strong fundamentals. We’ll look at three such marijuana companies that are well poised to soar if they report encouraging Q3 results.

Green Thumb Industries

The first pot stock on the list is Green Thumb Industries (CNSX:GTII), a company that manufactures, distributes, and sells cannabis products in the United States. GTII is a multi-state operator and has 49 dispensaries in 12 U.S. states.

Green Thumb stock is up 77% in 2020, valuing the company at a market cap of US$3.33 billion. This means the stock has a forward price-to-sales ratio of 6.5, which is not too expensive given its sales are forecast to reach US$745 million in 2021, up from just US$216 million in 2019.

In the second quarter, Green Thumb sales rose 168% year over year to US$119.6 million, and it is one of the fast-growing companies in the cannabis space. It has established its presence in Illinois, Nevada, and New Jersey — three states that could generate US$1 billion in annual pot sales by 2024.

Further, over 65% of Green Thumb sales are generated from high-margin derivatives products, allowing it to consistently report positive EBITDA margins.

Trulieve Cannabis

Another pot stock that has crushed peers in 2020 in Trulieve Cannabis (CNSX:TRUL). Shares of Trulieve have more than doubled this year, valuing it at a market cap of US$2.7 billion. This cannabis operator has delivered positive and expanding EBITDA for 10 consecutive quarters, making it one of the most profitable pot stocks.

In the June quarter, Trulieve’s sales were US$120.8 million, which indicated a sequential growth of 26%. It also reported a positive free cash flow of $39.6 million. It has a massive presence in Florida, one of the largest markets south of the border. Trulieve has 63 stores (out of a total of 65) in the sunshine state with a market share of over 50% in Florida.

Analysts tracking the company expect sales in Q3 to rise 85% to $131 million, while earnings are forecast at $0.19 per share. Trulieve has a forward price-to-sales multiple of 5.5, while its revenue is expected to grow by 94% in 2020.

A real estate investment trust

The final company on this list is Innovative Industrial Properties (NYSE:IIPR), a cannabis-focused real estate investment trust. IIPR leases out properties to medical marijuana companies and generates the majority of sales via rental income.

IIPR stock has returned approximately 600% since its IPO and is one of the top-performing companies in this space. In the June quarter, IIPR sales jumped 183% year over year to $24.3 million, and it ended the quarter with $50 million in cash and no debt.

IIPR has a forward yield of 3.5% and continues to focus on acquisitions to drive top-line growth. It has a market cap of US$2.6 billion and is valued at a price-to-sales multiple of 23.9, which might seem expensive. However, analysts forecast sales to rise by 147% to $110 million in 2020, while earnings growth is estimated at 60% for the year.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends Innovative Industrial Properties. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »